ERBB2 and invasive breast carcinoma: Additionally, in our study, the absence of HER-2/neu expression in BrCa patients was correlated with higher ccf-mtDNA quantity in the Adjuvant and Metastatic groups, and the presence of the ER receptor was associated with higher ccf-mtDNA levels in the Metastatic group.